Norway has some of the highest incidence
and mortality rates for colorectal cancer in
Europe (Bray et al, 2007), with one third of
patients having advanced disease at diagnosis
and 20% developing metastasis during their
illness trajectory (Sørbye et al, 2007). Cancer is
typically treated with surgery, radiotherapy,
chemotherapy, or some combination of the three,